Business Standard | Lupin to market MSD's pneumococcal vaccine in India Business Standard “Adults with comorbid conditions such as chronic lung disease, diabetes, chronic heart diseases, chronic liver diseases and immune compromised diseases, as well as adults aged more than 65, are at increased risk of pneumococcal disease, compared to ... Lupin to market MSD's 23-valent Pneumococcal Polysaccharide Vaccine for India MSD, Lupin enter strategic alliance to co-market MSD's 23-valent PPV for ... |
